Isoniazid and Rifampicin as Therapeutic Regimen in the Current Era: A Review

Journal of Tuberculosis Research
doi 10.4236/jtr.2014.21005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Isoniazid- And Rifampicin-Induced Thrombocytopenia

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Eudragit as the Material for the Production of Rifampicin and Isoniazid Microparticles

Journal of Physical Science
Materials ScienceAstronomyPhysics
2019English

Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Serum Total Bile Acid Levels in Patients Receiving Rifampicin and Isoniazid

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
1984English

Co-Encapsulation of Rifampicin and Isoniazid in Crude Soybean Lecithin Liposomes

South African Journal of Chemistry
Chemistry
2019English

Simultaneous Determination of Pyrazinamide, Rifampicin, Ethambutol, Isoniazid and Acetyl Isoniazid in Human Plasma by LC-MS/MS Method

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2018English

Dosage of Isoniazid and Rifampicin Poorly Predicts Drug Exposure in Tuberculosis Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Mitochondrial Damage and Drp1 Overexpression in Rifampicin- And Isoniazid-Induced Liver Injury Cell Model

Journal of Clinical and Translational Hepatology
2019English

Mycobacterium Tuberculosisresistance to Isoniazid and Rifampicin in a Hiv-1 Endemic Population in Western Kenya in 2014

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy